Can new image processing methods deliver reproducible radiomics?
In conclusion, we standardized eight types of convolutional filters for radiomics to ensure that the enhanced clinical insights that can be gained through their use can be validated and reproduced,” the authors wrote. “Going forward, developers should ensure compliance of their software with the proposed reference standards, and users are encouraged to use compliant software.”
The group has also posted a web-based tool to assist in checking compliance with these reference standards.
In the next phase of their work, the researchers are now working on standardizing image processing systems commonly used in deep-learn...
Source: AuntMinnie.com Headlines - February 7, 2024 Category: Radiology Authors: Erik L. Ridley Tags: Image Processing Source Type: news
Fluorescent green dye helps surgeons reduce complications after surgery for people with soft tissue sarcoma
A team of researchers at Mayo Clinic has discovered that using fluorescent green dye combined with imaging during surgery for soft tissue sarcoma can help surgeons determine what tissue may be at risk of poor healing. This information allows surgeons to change the wound closure to reduce the risk of complications as the patient heals. Soft tissue sarcoma forms in tissues that connect, support and surround other body structures, including muscle, fat, blood vessels, nerves, tendons… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 24, 2023 Category: Databases & Libraries Source Type: news
FDA Approves First Therapy for Progressive Desmoid Tumors
(MedPage Today) -- The FDA approved the first treatment for adults with progressive desmoid tumors, a rare type of benign soft-tissue sarcoma.
The approval of oral nirogacestat (Ogsiveo) stipulates use in patients with progressive tumors that... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - November 28, 2023 Category: American Health Source Type: news
FDA approves first therapy for rare type of non-cancerous tumors
The U.S. Food and Drug Administration approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment. Ogsiveo is the first drug to be approved for the treatment of patients with desmoid tumors, a rare subtype of soft tissue sarcomas. (Source: World Pharma News)
Source: World Pharma News - November 28, 2023 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors
The FDA approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment. Nirogacestat is a new molecular entity and the first drug to be approved for the treatment of patients with desmoid tumors, a subtype of soft tissue sarcomas. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 27, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
CT radiomics help characterize retroperitoneal sarcomas
CT radiomics can help clinicians predict the histological type and grade of retroperitoneal sarcomas, a study published in the November issue of The Lancet Oncology has found.The results could have "important implications for improving diagnosis and risk stratification" of these cancers, wrote a team led by Amani Arthur, MD, of the Institute of Cancer Research in London, U.K."Our radiomics model to predict histological subtype and grade presents a conceptual advance and an opportunity for a change in personalized care for patients with retroperitoneal sarcoma," the group noted.Retroperitoneal sarcomas are large and comp...
Source: AuntMinnie.com Headlines - November 2, 2023 Category: Radiology Authors: Kate Madden Yee Tags: Imaging Informatics Advanced Visualization Source Type: news
High-Intensity MRI Can ID Local Recurrence for Musculoskeletal STS
WEDNESDAY, Feb. 8, 2023 -- Magnetic resonance imaging (MRI) used at high intensity can detect clinically occult local recurrences (LRs) for musculoskeletal soft-tissue sarcoma (STS), according to a systematic review published online Jan. 26 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 8, 2023 Category: Pharmaceuticals Source Type: news
MRI shows promise for tracking recurrence of soft-tissue sarcoma
MRI shows promise as an effective way to identify recurrence of musculoskeleta...Read more on AuntMinnie.comRelated Reading:
Deep learning: A new frontier for musculoskeletal MRI
MRI shows negative impact of racket sports
Gadolinium MRI improves diagnosis of shoulder condition
SNMMI: AI can predict survival in sarcoma patients
MRI, ultrasound combined best assess baseball elbow pain (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 3, 2023 Category: Radiology Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLunsumio (follicular lymp...
Source: Roche Investor Update - February 2, 2023 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Basel, 2 February 2023Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLun...
Source: Roche Media News - February 2, 2023 Category: Pharmaceuticals Source Type: news
Shorter Regimen of Radiotherapy Safe for Soft Tissue Sarcoma
Findings with preoperative radiotherapy administered to dose of 42.75 Gy in 15 fractions for three weeks (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 17, 2022 Category: Cancer & Oncology Tags: Oncology, Radiology, Journal, Source Type: news
Shorter Regimen of Radiotherapy Safe for Soft Tissue Sarcoma
THURSDAY, Nov. 17, 2022 -- For adults with nonmetastatic soft tissue sarcomas of the extremities or superficial trunk, a moderately hypofractionated, shorter regimen of radiotherapy is safe, according to a study published online Nov. 4 in The Lancet... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 17, 2022 Category: Pharmaceuticals Source Type: news
This One Risk Factor Dominates for Soft Tissue Sarcoma After Breast Cancer
(MedPage Today) -- Although relatively rare, soft tissue sarcoma after breast cancer treatment was linked most strongly to treatment with radiation, according to data from two large U.S. cohorts of breast cancer survivors.
Radiotherapy was associated... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 13, 2022 Category: Hematology Source Type: news
Wales mother faces having leg, hip and pelvis removed after lump in foot turned out to be cancer
Sharon Walker, 53, from Nant-y-moel, Wales, noticed the lump on her foot in January last year and decided to visit her GP after becoming concerned. It turned out to be a soft-tissue sarcoma. (Source: the Mail online | Health)
Source: the Mail online | Health - October 13, 2022 Category: Consumer Health News Source Type: news
Is a Gastrointestinal Stromal Tumor a Soft Tissue Sarcoma?
Title: Is a Gastrointestinal Stromal Tumor a Soft Tissue Sarcoma?Category: Diseases and ConditionsCreated: 5/17/2022 12:00:00 AMLast Editorial Review: 5/17/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 17, 2022 Category: Cancer & Oncology Source Type: news
